Subclinical candiduria in patients with gastrointestinal malignancies: A preliminary study on the protective effect of a natural phytocompound

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 3, 2010, Pages 317-324

  Marotta, F ^a,b,g   Naito, Y ^a   Bishier, M P ^a   Jain, S ^c   Yadav, H ^d   Minelli, E ^b   Kumari, A ^e   Solimene, U ^b   Sollano, J ^f  

^a Immunology Research Institute and Clinic   (Japan)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e CH CHARAN SINGH UNIVERSITY   (India)

^f UNIVERSITY OF SANTO TOMAS   (Philippines)

^g NONE   (Italy)

Author keywords

Cancer; Candiduria; Phytocompound; Protection

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; K 712; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANDIDIASIS; CANDIDURIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TUMOR; GENOMICS; HUMAN; MALE; RECURRENT DISEASE; COMPLICATION; MICROBIOLOGY; MIDDLE AGED; PHYTOTHERAPY; PIMPINELLA; PSEUDOWINTERA; URINARY TRACT INFECTIONS; URINE;

CANDIDA;

AGED; CANDIDIASIS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PIMPINELLA; PSEUDOWINTERA; URINARY TRACT INFECTIONS; URINE;

EID: 77957922971     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jarvis WR. Epidemiology of nosocomial fungal infections with emphasis on Candida species. Clin Infect Dis 1995; 20:1526-30.
2. Nucci M. Candiduria in hospitalized patients: A review. Bras J Infec Dis 2000; 4:168-172.
3. Kobayashi CCBA, Fernandes OFL, Miranda KC, Souza ED, Silva MRR. Candiduria in hospital patients: A study prospective. Mycopathologia 2004; 158:49-52. (Pubitemid 39187852)
4. Akalm H et al. Persistent of candiduria in ICU catheterized patients is not linked to adherence and proteolytic activities of Candida strains. Intens Care Med 2004; 30:972-5.
5. Sobel JD. Controversies in the diagnosis of candiduria: What is the critical colony count? Infect Dis 2002; 4:81-83.
6. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992; 14(S):43-53.
7. Oravcova E, Lacka J, Drgona L. Funguria in cancer patients: analysis of risk factors, clinical presentation and outcome in 50 patients. Infection 1996; 24:319-23.
8. Eras P, Goldstein MJ, Sherlock P. Candida infection of the gastrointestinal tract. Medicine 1972; 51:367-79.
9. Pasqualotto AC, Rosa DD, Medeiros LR, Severo LC. Candidaemia and cancer: patients are not all the same. BMC Infect Dis 2006; 6:50-57.
10. Tortorano AM, Rigoni AL, Biraghi E, Prigitano A, Viviani MA and the FIMUA-ECMM candidaemia study group. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. J Antimicrob Chemother 2003; 52:679-82.
11. Krcmery V, Barnes AJ. Non-albicans Candida species causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50:243-60.
12. Meletiadis J, Chanock S, Walsh TJ. Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents. Pharmacogenomics 2008; 9:561-84 (Pubitemid 351803917)
13. Marotta F, Barreto R, Kawakita S, Minelli E, Pavasuthipaisit K, Lorenzetti A, Nishiwaki M, Okura R. Protein-calorie malnutrition is an aggravating factor of ischemia-reperfusion-induced candida translocation through the gut: preventive effect of a phytotherapeutic compound. Chin J Dig Dis 2006; 7:33-38.
14. Naito Y, Wu CC, Seal MG. Protective effect of a polygodial/anethole- containing natural product against Candida albicans gastrointestinal colonization and dissemination. Intern Med J 2003; 8:3-9. (Pubitemid 32377824)
15. Taniguchi M, Yano Y, Tada E. Mode of action of Polygodial, an antifungal sesquiterpene dialdehyde. Agric Biol Chem 1988; 52:1409-14.
16. Nakajima J, Papaah P, Yoshizawa M, Marotta F, Nakajima T, Mihara S, Minelli E. Effect of a novel phytocompound on mucosal candidiasis: further evidences from an ex vivo study. Chin J Dig Dis 2007; 8:48-51. (Pubitemid 46189210)
17. Himejima M, Kubo I. Antifungal activity of polygodial in combination with anethole and indole against Candida albicans. J Agric Food Chem 1993; 41:1776-9.
18. Kurtzman CP, Fell JW. The Yeasts, a Taxonomic Study, 4th ed., Elsevier, New York, 1998; pp. 891-947.
19. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-89.
20. Bukhary ZA. Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl 2008; 19:350-60.
21. Sobel JD. Management of asymptomatic candiduria. Int J Ant Agents 2000; 11:285-8
22. Ahmad S, Khan Z, Mustafa SA, Khan ZU. Epidemiology of Candida colonization in an intensive care unit of a teaching hospital in Kuwait. Med Mycol 2003; 41:487-93.
23. Krcmery V, Matejicka F, Pichnova E, Jurga L, Sulcova M, Kunová A, West D. Documented fungal infections after prophylaxis or therapy with wide spectrum antibiotics: relationship between certain fungal pathogens and particular antimicrobials? J Chemother 1999; 11:385-90.
24. Maraki S, Barbounakis E, Chatzinikolaou I, Anatoliotakis N, Plataki M, Tselentis Y, Samonis G, Chatzinikolau I. Effects of cefepime, cefixime and ceftibuten on murine gut colonization by Candida albicans. Chemotherapy 1998; 44:405-8. (Pubitemid 28468492)
25. Samonis G, Gikas A, Toloudis P, Maraki S, Vrentzos G, Tselentis Y, Tsaparas N, Bodey G. Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis 1994; 13:665-7. (Pubitemid 24286870)
26. Navarro I, Basset JF, Hebbe S, Major SM, Werner T, Howsham C, Bräckow J, Barrett AG. Biomimetic synthesis of resorcylate natural products utilizing late stage aromatization: concise total syntheses of the marine antifungal agents 15G256iota and 15G256beta. J Am Chem Soc 2008; 130:10293-8.
27. Tuntiwachwuttikul P, Butsuri Y, Sukkoet P, Prawat U, Taylor WC. Anthraquinones from the roots of Prismatomeris malayana. Nat Prod Res 2008; 22:962-8.
28. Metugriachuk Y, Kuroi O, Pavasuthipaisit K, Tsuchiya J, Minelli E, Okura R, Fesce E, Marotta F. In view of an optimal gut antifungal therapeutic strategy: an in vitro susceptibility and toxicity study testing a novel phyto-compound. Chin J Dig Dis 2005; 6:98-103.
29. Telenti A. Steckelberg, JM. Stockman L. Edson RS, Roberts GD. Quantitative blood cultures in candidemia. Mayo Clin Proc 1991; 66:1120-23.
30. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis: disseminated versus single organ infection. Diagn Microbiol Infect Dis 1993; 17:103-9.
31. Febré N, Silva V, Medeiros EAS, Wey SB, Colombo AL, Fischman O. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catherization. J Clin Microbiol 1999; 37:1584-6. (Pubitemid 29187842)
32. Redmond HP, Shou J, Kelly CJ, Leon P, Daly JM. Protein-calorie malnutrition impairs host defense against Candida albicans. J Surg Res 1991; 50:552-9.
33. Choi JH, Ko HM, Kim JW, Lee HK, Han SS, Chun SB, Im SY. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. J Immunol 2001; 166:5139-44.
34. Howes MJ, Houghton PJ, Barlow DJ, Pocock VJ, Milligan SR. Assessment of estrogenic activity in some common essential oil constituents. J Pharm Pharmacol 2002; 54:1521-8.